✦ LIBER ✦

P281 - The prevalence of antibodies against cyclic citrullinated peptide (anti-CCP) is low in patients with inflammatory bowel disease with or without arthritis

✍ Scribed by K. Papamichael; I. Theodoropoulos; C. Karakoidas; A. Tsirogianni; A. Smyrnidis; G. Agalos; N. Kanellopoulos; G. Antonakis; A. Christidou; C. Papasteriadi; G.J. Mantzaris

Book ID: 119636396
Publisher: Oxford University Press
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 3
Category: Article
ISSN: 1873-9946
DOI: 10.1016/s1873-9946(09)60308-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibodies against cyclic citrullinated

Antibodies against cyclic citrullinated peptide (CCP) in inflammatory bowel disease patients with or without arthritic manifestations

✍ Ioannis E. Koutroubakis; Konstantinos Karmiris; Leonidas Bourikas; Elias A. Kour 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Prevalence of IgA class antibodies to cy

Prevalence of IgA class antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease (IBD)

✍ Hans-Jacob Haga; Øyvind Palm; Elisabeth Peen 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 74 KB

Prevalence of anti cyclic citrullinated

Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity

✍ Sargunan SOCKALINGAM; Chow Sook KHUAN; Pavai STHANESHWAR 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 119 KB

P312 - Prevalence of antibodies against

P312 - Prevalence of antibodies against thyroglobulin (anti-Tg) and thyroid peroxidase (anti-TPO) in patients with inflammatory bowel disease on scheduled infliximab or conventional treatment: a two years follow up study

✍ K. Papamichael; S. Ballas; A. Smyrnidis; C. Karakoidas; G. Agalos; N. Kanellopou 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 49 KB